4th Quarter - Termination

WALTER CONSULTING for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$20,000
Expenses
—
Terminated
Dec 31, 2016

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration

LobbyistCovered position, as disclosed
SARAH WALTER Former Legislative Director/Chief Counsel, Sen. John Breaux

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 696 (114th), S. 506 (114th)

Pharmacy PHA

H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act

LobbyistCovered position, as disclosed
SARAH WALTER Former Legislative Director/Chief Counsel, Senator John Breaux

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 471 (114th), S. 483 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.